相关实验视频

Updated: Jun 10, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

关于I型干扰素作为人类呼吸道同胞病毒F蛋白的粘膜辅助剂的初步研究

Hongqiao Hu¹, Li Zhang^1,2, Lei Cao¹

¹NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO WPRO Regional Reference Measles/Rubella Laboratory, Beijing 102206, China.

|November 26, 2024

概括

小鼠干扰素 (IFN-小鼠) 作为人类呼吸道同胞病毒 (HRSV) 重组蛋白质疫苗的优质粘膜辅助剂,在小鼠中提供了与人类干扰素 (IFN-人类) 相比更好的保护. 这项研究突出了IFN小鼠.

科学领域:

免疫学和病毒学
疫苗开发疫苗开发

背景情况:

人类呼吸道同胞性病毒 (HRSV) 对健康构成重大挑战,尤其对婴儿和老年人来说.
目前的HRSV疫苗研究包括内减弱活体和载体疫苗,其中一些正在进入II期临床试验.
用于粘膜输送的重组蛋白疫苗需要有效的粘膜辅助剂,如I型干扰素 (IFN),以增强免疫反应.

研究的目的:

评估内HRSV融合蛋白 (F) 与人类α2b干扰素 (IFN-人类) 或小鼠α2干扰素 (IFN-小鼠) 结合作为粘膜辅助剂的免疫性和保护功效.
在小鼠模型中比较IFN-人类和IFN-小鼠作为辅助剂的有效性.

主要方法:

在BALB/c小鼠中,单独使用HRSV融合蛋白 (F) 或与IFN-人类或IFN-小鼠结合,进行了鼻腔免疫.
通过测量中和抗体标位,特定IgA,IgG,IgG1水平和淋巴细胞细胞因子分泌 (IFN-γ,IL-4) 来评估免疫性.
用肺中的病毒载量,体重恢复和挑战后的肺病理损伤来评估保护功效.

主要成果:

与单独的F相比,F + IFN人类和F + IFN小鼠组都显示出显著增加的中和抗体标位和增强的IFN-γ和IL-4分泌量.
F + IFN-小鼠免疫接种导致了最高的中和抗体标位,最低的肺病毒负载和最快的体重恢复.
F+IFN小鼠组表现出最轻微的肺病理损伤,这表明它们具有更高的保护性.

结论:

小鼠干扰素 (IFN-小鼠) 作为HRSV重组蛋白质疫苗的强效粘膜辅助剂.
与IFN-人类相比,IFN-小鼠在与HRSV融合蛋白一起使用时,在小鼠模型中表现出更好的保护作用.
这些发现支持IFN小鼠作为粘膜辅助剂的潜力,用于开发有效的HRSV疫苗.

关键词:

人类呼吸道同胞性病毒粘膜的辅助剂粘膜的辅助剂保护性影响保护性影响这是一种I型干扰子.

更多相关视频

Rescue of Recombinant Newcastle Disease Virus from cDNA

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

相关概念视频

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...